𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain

✍ Scribed by Miguel Angel Benítez-Rosario; Manuel Feria; Antonio Salinas-Martín; Luis Pedro Martínez-Castillo; José Javier Martín-Ortega


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
169 KB
Volume
101
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Long-term cancer pain management in morp
✍ Kyriaki Mystakidou; Eleni Tsilika; Efi Parpa; Vassilios Kouloulias; Ioannis Kouv 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB

## Abstract There is emerging data supporting the use of TTS‐F (transdermal therapeutic system‐fentanyl) in opioid naive patients. Our study examines the safety and efficacy of TTS‐F in the long‐term control of cancer pain in opioid naive patients and those transferring from oral morphine. Pain was

Opioid rotation in patients with cancer
✍ Eduardo Bruera; Jose Pereira; Sharon Watanabe; Michelle Belzile; Norma Kuehn; Jo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

## BACKGROUND. When a change of opioid is considered, equianalgesic dose tables are used. These tables generally propose a dose ratio of 5:l between morphine and hydromorphone. In the case of a change from subcutaneous hydromorphone to methadone, dose ratios ranging from 1:6 to 1:10 are proposed.

A safe and effective method for converti
✍ Craig A. Kornick; Juan Santiago-Palma; Glenn Schulman; Peter C. O'Brien; Stephen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract ## BACKGROUND The delayed effects (12–16 hours) of transdermal fentanyl make dose titration difficult during acute exacerbations of cancer pain. Patients at the authors' institution routinely are switched from transdermal to intravenous (IV) fentanyl using a 1:1 (transdermal:IV) conver

Effects of switching to long-acting inje
✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral